Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-B $

Department of Neurology, Washington University, St. Louis, MO 63130, USA Neurology, Bryan ADRC, Duke University, Durham, NC 27706, USA Neuroscience Discovery Research, Eli Lilly and Co., Indianapolis, IN 46285, USA Center for Neurologic Diseases, Brigham and Woman’s Hospital and Department of Neurology, Harvard Medical School, Boston, MA 02115, USA Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA Molecular Neurobiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan Department of Molecular Biology and Pharmacology, Hope Center for Neurological Disorders, Alzheimer’s Disease Research Center, Washington University, St. Louis, MO 63110, USA

[1]  L. Bernier,et al.  Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain* , 2004, Journal of Biological Chemistry.

[2]  S. Paul,et al.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides , 2004, Nature Medicine.

[3]  Bruce J Aronow,et al.  ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition Evidence that ApoE Regulates Extracellular Aβ Metabolism In Vivo , 2004, Neuron.

[4]  M. Vitek,et al.  APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response* , 2003, Journal of Biological Chemistry.

[5]  T. Walz,et al.  Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Xianlin Han,et al.  Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein. , 2002, Journal of biochemistry.

[7]  K. Becker.  APOE genotype is a major predictor of long-term progression of disability in MS , 2001, Neurology.

[8]  Xianlin Han,et al.  Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice , 2001, Neurochemistry International.

[9]  D. Michaelson,et al.  The effects of APOE genotype on age at onset and progression of neurodegenerative diseases , 2001, Neurology.

[10]  R. Demattos,et al.  Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. , 2001, Journal of lipid research.

[11]  T. Kishimoto,et al.  Isolation and characterization of a new immortal rat astrocyte with a high expression of NGF mRNA , 2001, Neuroscience Research.

[12]  D. Holtzman,et al.  Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.

[13]  A Rostagno,et al.  Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. , 2000, The Biochemical journal.

[14]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Fagan,et al.  Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (−/−), and Human apoE Transgenic Mice* , 1999, The Journal of Biological Chemistry.

[16]  Matthias Orth,et al.  Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.

[17]  R. Martins,et al.  Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner , 1999, Neuroscience.

[18]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[19]  J. Poirier,et al.  Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures. , 1999, Brain research. Molecular brain research.

[20]  A. Fagan,et al.  Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. , 1999, The Journal of clinical investigation.

[21]  N. Maeda,et al.  Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.

[22]  D. Holtzman,et al.  Nascent Astrocyte Particles Differ from Lipoproteins in CSF , 1998, Journal of neurochemistry.

[23]  R. Demattos,et al.  A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.

[24]  S. Paul,et al.  Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.

[25]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[26]  R. Martins,et al.  Characterization of the Binding of Amyloid‐β Peptide to Cell Culture‐Derived Native Apolipoprotein E2, E3, and E4 Isoforms and to Isoforms from Human Plasma , 1997, Journal of neurochemistry.

[27]  T. Morgan,et al.  Astrocytes and Microglia Respond to Estrogen with Increased apoE mRNAin Vivoandin Vitro , 1997, Experimental Neurology.

[28]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[29]  B. Hyman,et al.  Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .

[30]  G. Getz,et al.  Purification of Apolipoprotein E Attenuates Isoform-specific Binding to -Amyloid (*) , 1995, The Journal of Biological Chemistry.

[31]  R. James,et al.  Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. , 1995, Biochimica et biophysica acta.

[32]  T. Wisniewski,et al.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.

[33]  P. Lansbury,et al.  Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Young,et al.  Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. , 1991, The Journal of clinical investigation.

[35]  G. Weskamp,et al.  Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen , 1989, Neuron.

[36]  E. Krul,et al.  Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. , 1988, Journal of lipid research.

[37]  R. Mahley,et al.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. , 1987, Biochimica et biophysica acta.

[38]  J. Taylor,et al.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.

[39]  P. Dawson,et al.  Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates. , 1985, The Journal of biological chemistry.

[40]  G. Vega,et al.  Apolipoproteins in human cerebrospinal fluid. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[41]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[42]  森川 将行.  Isolation and characterization of a new immortal rat astrocyte with a high expression of NGF mRNA , 2001 .

[43]  Donald,et al.  Isoform-specific Binding of Apolipoprotein E to p-Amyloid* , 2001 .

[44]  B. Dastugue,et al.  [Apolipoprotein E and Alzheimer's disease]. , 1998, Annales de biologie clinique.

[45]  J. Ma,et al.  Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. , 1994, Nature.

[46]  D. Choi,et al.  4 – Cytotoxicity in Murine Neocortical Cell Culture , 1993 .

[47]  J. Roberts,et al.  Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. , 1990, Neuron.

[48]  J. Taylor,et al.  Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.